Dementia Prevention in Clinical Practice

Alzheimer's, cardiovascular, and other chronic diseases; biomarkers, lifestyle, supplements, drugs, and health care.
Post Reply
Plumster
Senior Contributor
Senior Contributor
Posts: 620
Joined: Mon Oct 30, 2017 6:19 pm

Dementia Prevention in Clinical Practice

Post by Plumster »

I did a search and did not find this article on the forum, so here it is with a link to the full article: "Dementia Prevention in Clinical Practice," Seminars in Neurology, vol. 42, no. 5 (2022). DOI: 10.1055/s-0042-1759580. The article, authored by Kellyann Niotis, Kiarra Akiyoshi, Caroline Carlton, and Richard Isaacson, considers several risk factors: Age, Biological Sex, Genetics, Dietary Patterns, Dietary Components, Vitamins, and Supplements, Alcohol, Exercise, Hypertension, Hyperlipidemia, Metabolic Comorbidities, Education and Cognitive Engagement, Social Interaction, Mental Health and Stress, Sleep, and Dental diseases.
Abstract
Over 55 million people globally are living with dementia and, by 2050, this number is projected to increase to 131 million. This poses immeasurable challenges for patients and their families and a significant threat to domestic and global economies. Given this public health crisis and disappointing results from disease-modifying trials, there has been a recent shift in focus toward primary and secondary prevention strategies. Approximately 40% of Alzheimer's disease (AD) cases, which is the most common form of dementia, may be prevented or at least delayed. Success of risk reduction studies through addressing modifiable risk factors, in addition to the failure of most drug trials, lends support for personalized multidomain interventions rather than a “one-size-fits-all” approach. Evolving evidence supports early intervention in at-risk patients using individualized interventions directed at modifiable risk factors. Comprehensive risk stratification can be informed by emerging principals of precision medicine, and include expanded clinical and family history, anthropometric measurements, blood biomarkers, neurocognitive evaluation, and genetic information. Risk stratification is key in differentiating subtypes of dementia and identifies targetable areas for intervention. This article reviews a clinical approach toward dementia risk stratification and evidence-based prevention strategies, with a primary focus on AD.
e3/4 MTHFR C677T/A1298C COMT V158M++ COMT H62H++ MTRR A66G ++ HLA DR
AKA
Support Team
Support Team
Posts: 107
Joined: Wed Aug 09, 2017 10:15 am
Location: Cleveland, OH

Re: Dementia Prevention in Clinical Practice

Post by AKA »

Plumster wrote: Mon Jan 30, 2023 11:20 am I did a search and did not find this article on the forum, so here it is with a link to the full article: "Dementia Prevention in Clinical Practice," Seminars in Neurology, vol. 42, no. 5 (2022). DOI: 10.1055/s-0042-1759580. The article, authored by Kellyann Niotis, Kiarra Akiyoshi, Caroline Carlton, and Richard Isaacson, considers several risk factors: Age, Biological Sex, Genetics, Dietary Patterns, Dietary Components, Vitamins, and Supplements, Alcohol, Exercise, Hypertension, Hyperlipidemia, Metabolic Comorbidities, Education and Cognitive Engagement, Social Interaction, Mental Health and Stress, Sleep, and Dental diseases.
Thanks for this article share, Plumster! It's a great summation and resource. :D
Post Reply